When ads are banned, news media will continue to avoid negative coverage of pharma and the drugs they make. Pharma pays HHS/DARPA and some of it's employees royalties on the drugs pharma sells. HHSDARPA also pays the media for the correct messaging. The financial incentive still exists even if ads are banned.
When ads are banned, news media will continue to avoid negative coverage of pharma and the drugs they make. Pharma pays HHS/DARPA and some of it's employees royalties on the drugs pharma sells. HHSDARPA also pays the media for the correct messaging. The financial incentive still exists even if ads are banned.
When ads are banned, news media will continue to avoid negative coverage of pharma and the drugs they make. Pharma pays HHS/DARPA and some of it's employees royalties on the drugs pharma sells. HHSDARPA also pays the media for the correct messaging. The financial incentive still exists even if ads are banned.